Cumberland Pharmaceuticals Stock Price To Sales

CPIX Stock

USD 1.37 0.26 23.42%

Cumberland Pharmaceuticals fundamentals help investors to digest information that contributes to Cumberland Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cumberland Stock. The fundamental analysis module provides a way to measure Cumberland Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cumberland Pharmaceuticals stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	0.65	0.61

Price To Sales Ratio is likely to drop to 0.61 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cumberland Pharmaceuticals Company Price To Sales Analysis

Cumberland Pharmaceuticals' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Cumberland Pharmaceuticals Price To Sales

0.52 X

Most of Cumberland Pharmaceuticals' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cumberland Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cumberland Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Cumberland Pharmaceuticals is extremely important. It helps to project a fair market value of Cumberland Stock properly, considering its historical fundamentals such as Price To Sales. Since Cumberland Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cumberland Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cumberland Pharmaceuticals' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Long Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.64	0.87	-0.23	0.39	0.33	0.49	0.43	0.75	0.19	0.66	0.4	0.76	0.22	-0.31	0.27	0.1	0.02	-0.15	-0.01
Total Stockholder Equity	0.64		0.53	-0.82	0.85	-0.38	-0.18	-0.42	0.94	0.3	-0.05	-0.41	0.91	-0.3	0.45	-0.54	0.05	0.49	0.51	0.25
Current Deferred Revenue	0.87	0.53		-0.1	0.14	0.5	0.51	0.4	0.6	0.11	0.57	0.32	0.68	0.23	-0.47	0.25	0.19	-0.36	-0.39	-0.36
Net Debt	-0.23	-0.82	-0.1		-0.85	0.74	0.4	0.7	-0.74	-0.36	0.48	0.64	-0.75	0.52	-0.81	0.73	0.0	-0.65	-0.8	-0.55
Retained Earnings	0.39	0.85	0.14	-0.85		-0.63	-0.35	-0.54	0.74	0.43	-0.13	-0.52	0.72	-0.44	0.69	-0.64	0.0	0.81	0.83	0.69
Accounts Payable	0.33	-0.38	0.5	0.74	-0.63		0.73	0.84	-0.23	0.0	0.71	0.79	-0.25	0.58	-0.95	0.82	0.33	-0.71	-0.87	-0.65
Net Receivables	0.49	-0.18	0.51	0.4	-0.35	0.73		0.79	-0.02	0.1	0.68	0.7	0.08	0.53	-0.72	0.63	0.16	-0.54	-0.63	-0.3
Total Liab	0.43	-0.42	0.4	0.7	-0.54	0.84	0.79		-0.22	-0.13	0.84	0.96	-0.17	0.62	-0.89	0.95	0.06	-0.55	-0.79	-0.31
Total Current Assets	0.75	0.94	0.6	-0.74	0.74	-0.23	-0.02	-0.22		0.3	0.05	-0.17	0.91	-0.29	0.32	-0.31	0.1	0.43	0.38	0.21
Short Term Debt	0.19	0.3	0.11	-0.36	0.43	0.0	0.1	-0.13	0.3		0.05	-0.09	0.2	-0.19	0.18	-0.16	0.83	0.37	0.41	0.32
Intangible Assets	0.66	-0.05	0.57	0.48	-0.13	0.71	0.68	0.84	0.05	0.05		0.75	0.09	0.47	-0.77	0.68	0.11	-0.28	-0.53	-0.16
Long Term Debt	0.4	-0.41	0.32	0.64	-0.52	0.79	0.7	0.96	-0.17	-0.09	0.75		-0.19	0.6	-0.82	0.97	0.1	-0.44	-0.72	-0.28
Common Stock	0.76	0.91	0.68	-0.75	0.72	-0.25	0.08	-0.17	0.91	0.2	0.09	-0.19		-0.17	0.28	-0.31	-0.07	0.28	0.32	0.26
Property Plant Equipment	0.22	-0.3	0.23	0.52	-0.44	0.58	0.53	0.62	-0.29	-0.19	0.47	0.6	-0.17		-0.59	0.61	-0.09	-0.4	-0.63	-0.36
Net Tangible Assets	-0.31	0.45	-0.47	-0.81	0.69	-0.95	-0.72	-0.89	0.32	0.18	-0.77	-0.82	0.28	-0.59		-0.84	-0.17	0.78	0.93	0.66
Long Term Debt Total	0.27	-0.54	0.25	0.73	-0.64	0.82	0.63	0.95	-0.31	-0.16	0.68	0.97	-0.31	0.61	-0.84		0.07	-0.53	-0.79	-0.33
Short Long Term Debt	0.1	0.05	0.19	0.0	0.0	0.33	0.16	0.06	0.1	0.83	0.11	0.1	-0.07	-0.09	-0.17	0.07		-0.02	0.01	-0.18
Net Invested Capital	0.02	0.49	-0.36	-0.65	0.81	-0.71	-0.54	-0.55	0.43	0.37	-0.28	-0.44	0.28	-0.4	0.78	-0.53	-0.02		0.89	0.78
Net Working Capital	-0.15	0.51	-0.39	-0.8	0.83	-0.87	-0.63	-0.79	0.38	0.41	-0.53	-0.72	0.32	-0.63	0.93	-0.79	0.01	0.89		0.78
Capital Stock	-0.01	0.25	-0.36	-0.55	0.69	-0.65	-0.3	-0.31	0.21	0.32	-0.16	-0.28	0.26	-0.36	0.66	-0.33	-0.18	0.78	0.78

Click cells to compare fundamentals

Cumberland Price To Sales Historical Pattern

Today, most investors in Cumberland Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cumberland Pharmaceuticals' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cumberland Pharmaceuticals price to sales as a starting point in their analysis.

Cumberland Pharmaceuticals Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Cumberland Pharmaceuticals

Price To Sales Ratio Over Time

Cumberland Price To Sales Ratio

Price To Sales Ratio

0.61

At this time, Cumberland Pharmaceuticals' Price To Sales Ratio is fairly stable compared to the past year.

Based on the latest financial disclosure, Cumberland Pharmaceuticals has a Price To Sales of 0.523 times. This is 97.56% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 95.42% higher than that of the company.

Cumberland Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cumberland Pharmaceuticals' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cumberland Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cumberland Pharmaceuticals by comparing valuation metrics of similar companies.

Cumberland Pharmaceuticals is currently under evaluation in price to sales category among its peers.

Cumberland Pharmaceuticals Current Valuation Drivers

We derive many important indicators used in calculating different scores of Cumberland Pharmaceuticals from analyzing Cumberland Pharmaceuticals' financial statements. These drivers represent accounts that assess Cumberland Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cumberland Pharmaceuticals' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	79.3M	44.7M	69.6M	25.6M	29.4M	28.0M
Enterprise Value	72.6M	37.1M	58.6M	25.7M	29.6M	28.1M

Cumberland Fundamentals

	Return On Equity	-0.36
	Return On Asset	-0.0564
	Profit Margin	(0.30) %
	Operating Margin	(0.19) %
	Current Valuation	23.25 M
	Shares Outstanding	14.04 M
	Shares Owned By Insiders	44.72 %
	Shares Owned By Institutions	14.68 %
	Number Of Shares Shorted	89.61 K
	Price To Earning	(16.05) X
	Price To Book	0.63 X
	Price To Sales	0.52 X
	Revenue	39.55 M
	Gross Profit	32.89 M
	EBITDA	153.32 K
	Net Income	(6.28 M)
	Cash And Equivalents	18.22 M
	Cash Per Share	1.24 X
	Total Debt	18.43 M
	Debt To Equity	0.50 %
	Current Ratio	1.80 X
	Book Value Per Share	1.77 X
	Cash Flow From Operations	6.09 M
	Short Ratio	1.20 X
	Earnings Per Share	(0.76) X
	Target Price	8.5
	Number Of Employees	91
	Beta	0.22
	Market Capitalization	19.24 M
	Total Asset	81.78 M
	Retained Earnings	(17.49 M)
	Working Capital	7.73 M
	Current Asset	66.96 M
	Current Liabilities	11.69 M
	Net Asset	81.78 M

About Cumberland Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cumberland Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cumberland Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cumberland Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC